Inhibition of Functional Hyaluronan-CD44 Interactions in CD133-positive Primary Human Ovarian Carcinoma Cells by Small Hyaluronan Oligosaccharides.
about
Dangerous liaisons: molecular basis for a syndemic relationship between Kaposi's sarcoma and P. falciparum malariaLipid Raft-Mediated Regulation of Hyaluronan-CD44 Interactions in Inflammation and CancerBreaching the Castle Walls: Hyaluronan Depletion as a Therapeutic Approach to Cancer TherapyRegulation of ovarian cancer stem cells or tumor-initiating cellsInteraction of low molecular weight hyaluronan with CD44 and toll-like receptors promotes the actin filament-associated protein 110-actin binding and MyD88-NFκB signaling leading to proinflammatory cytokine/chemokine production and breast tumor invaIn vitro and in vivo prostate cancer metastasis and chemoresistance can be modulated by expression of either CD44 or CD147High expression of Lewis y antigen and CD44 is correlated with resistance to chemotherapy in epithelial ovarian cancersInduction of hyaluronan production by oncogenic KSHV and the contribution to viral pathogenesis in AIDS patients.Using heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancerCooperative roles for emmprin and LYVE-1 in the regulation of chemoresistance for primary effusion lymphoma.CD147, CD44, and the epidermal growth factor receptor (EGFR) signaling pathway cooperate to regulate breast epithelial cell invasiveness.Stem cell pathways contribute to clinical chemoresistance in ovarian cancerThe hypoxic microenvironment upgrades stem-like properties of ovarian cancer cells.Hyaluronan inhibits postchemotherapy tumor regrowth in a colon carcinoma xenograft model.Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer.Ovarian cancer stem cells express ROR1, which can be targeted for anti-cancer-stem-cell therapy.Role of versican, hyaluronan and CD44 in ovarian cancer metastasis.Ovarian cancer stem cells: are they real and why are they important?Membranous expressions of Lewis y and CAM-DR-related markers are independent factors of chemotherapy resistance and poor prognosis in epithelial ovarian cancer.Ovarian cancer stem cell markers: prognostic and therapeutic implications.Mechanisms involved in enhancement of the expression and function of aggrecanases by hyaluronan oligosaccharidesCleaved CD44 intracellular domain supports activation of stemness factors and promotes tumorigenesis of breast cancerSignificance of CD44 and CD24 as cancer stem cell markers: an enduring ambiguityThe liberation of CD44 intracellular domain modulates adenoviral vector transgene expression.Hyaluronan synthase and hyaluronidase expression in serous ovarian carcinoma is related to anatomic site and chemotherapy exposure.CUDR promotes liver cancer stem cell growth through upregulating TERT and C-Myc.CD147-dependent heterogeneity in malignant and chemoresistant properties of cancer cellsImaging of homeostatic, neoplastic, and injured tissues by HA-based probes.Emmprin and KSHV: new partners in viral cancer pathogenesis.HAb18G/CD147 promotes pSTAT3-mediated pancreatic cancer development via CD44s.Differential Expression of Key Signaling Proteins in MCF10 Cell Lines, a Human Breast Cancer Progression ModelSerglycin proteoglycan is required for multiple myeloma cell adhesion, in vivo growth, and vascularization.hPaf1/PD2 interacts with OCT3/4 to promote self-renewal of ovarian cancer stem cells.Therapeutic targeting of hyaluronan in the tumor stroma.Lung cancer stem cells and implications for future therapeutics.Investigating molecular profiles of ovarian cancer: an update on cancer stem cells.Targeting hyaluronic acid family for cancer chemoprevention and therapy.EMMPRIN in gynecologic cancers: pathologic and therapeutic aspects.Hyaluronan oligomers sensitize chronic myeloid leukemia cell lines to the effect of Imatinib.Carcinoma Cell Hyaluronan as a "Portable" Cancerized Prometastatic Microenvironment.
P2860
Q21131129-EA83DAC2-39AA-4E27-86AA-461BADCF3062Q26782792-6EB6525E-87CF-41B0-B6DA-617AAF821011Q26784055-C6CA2F10-339A-4FAD-9A86-D723CCB5864DQ26853096-309D8594-5E7F-4DCF-A740-0FFB8E3E99F5Q28394879-D464A0C8-9338-4DF6-800C-038918E6D2E4Q28482047-A4A4C051-B156-4828-BF86-6DE2DF1D188AQ28487341-6DB84460-EB6C-4A41-8E3C-48465C0797D1Q30357883-EE567C4A-33AD-4E4A-AA01-66FC4629CA58Q30409503-241506CF-04D1-45EB-BB92-8C8FA0BEA1E1Q30418735-56027F1E-4557-4371-AFA0-D1001B31040BQ30431290-4BBD2E22-CF8A-4B53-91AA-BEA97444B016Q34092005-93761F87-1E09-4402-891C-EDCE87D1216EQ34285178-CFCBE19C-1638-4976-90A7-277EE1F68A21Q34300214-85C3083A-1083-4DC9-BF44-89B5324AA42DQ34420393-D6F44173-F60C-42E7-BC52-72264970074DQ34448718-428D022E-9EEE-46C7-8CE7-8E3A5FEC7547Q34874835-EFE22318-28E3-4583-83ED-36494589DACEQ35047699-E0B94BD4-98AD-46A6-ADCB-D3146ABD2C26Q35402326-32B83877-449C-4794-ADCB-B9C5BF1EB084Q35606242-4D578067-6191-4F96-B93E-13A23DB485FFQ35621664-5A0394C7-BC59-4506-9ABB-2BD1D7737C9AQ35832214-A3B21FA6-2E9D-4174-AABC-0371DF404EA1Q36014411-C023BCCB-CD46-4416-8B9E-C0EDE609B945Q36294870-55362D5B-17D3-4E3B-B3B1-86392C390E9BQ36396500-5AEB5D8B-CE0B-4C1C-9833-D85A144F3466Q36562166-5C2024DF-69C9-4277-8A34-9F98BFFA3398Q36582881-A6844A51-5AA5-4B98-91F6-85F0360CC7A4Q36856835-2A9D1D10-4675-486F-B188-AD84C21E04B0Q37057685-C9F5254B-4FD9-4871-B556-2D674A04F316Q37416242-1B47061D-5803-4B3F-841E-DFCA05AE48CDQ37591395-3464EF84-F112-44E7-83F8-5AA785458174Q37608433-6505C3AF-83F5-4E60-B97B-A264DC67C22EQ37716449-E75ABC77-4205-48EF-905D-C5A92640D5A8Q38161392-877A2755-D64A-483A-8380-8A7A9FBA59BFQ38189297-7615E36E-3D61-450E-BA15-07F79B51B0E4Q38203882-F9B420CC-4D92-4C6E-B8E5-A877927C0186Q38235792-920EF4AE-50F8-46F1-B632-76B2F219F656Q38476060-2E984C64-3A45-418A-94F0-20EB39247DC8Q38818540-F2D312D4-85D6-4271-8D7D-E184A3D30ED8Q38838567-74618EA5-595D-49BF-9B0B-CBA79994A687
P2860
Inhibition of Functional Hyaluronan-CD44 Interactions in CD133-positive Primary Human Ovarian Carcinoma Cells by Small Hyaluronan Oligosaccharides.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Inhibition of Functional Hyalu ...... l Hyaluronan Oligosaccharides.
@ast
Inhibition of Functional Hyalu ...... l Hyaluronan Oligosaccharides.
@en
type
label
Inhibition of Functional Hyalu ...... l Hyaluronan Oligosaccharides.
@ast
Inhibition of Functional Hyalu ...... l Hyaluronan Oligosaccharides.
@en
prefLabel
Inhibition of Functional Hyalu ...... l Hyaluronan Oligosaccharides.
@ast
Inhibition of Functional Hyalu ...... l Hyaluronan Oligosaccharides.
@en
P2093
P2860
P1476
Inhibition of Functional Hyalu ...... l Hyaluronan Oligosaccharides.
@en
P2093
Bryan P Toole
G Daniel Grass
Lauren B Tolliver
Mark G Slomiany
Yiping Zeng
P2860
P304
P356
10.1158/1078-0432.CCR-09-2317
P407
P577
2009-12-01T00:00:00Z